CA - HLS Therapeutics GAAP EPS of -$0.20 revenue of $15.68M March, 16 2023 08:54 AM CA Inc. 2023-03-16 08:54:54 ET HLS Therapeutics press release ( OTCPK:HLTRF ): Q4 GAAP EPS of -$0.20. Revenue of $15.68M (-0.1% Y/Y). For further details see: HLS Therapeutics GAAP EPS of -$0.20, revenue of $15.68M